相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults
Niklas Mattsson et al.
NEUROBIOLOGY OF AGING (2014)
The Interaction of Amyloid β and the Receptor for Advanced Glycation Endproducts Induces Matrix Metalloproteinase-2 Expression in Brain Endothelial Cells
Huan Du et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2012)
Limited cleavage of tau with matrix-metalloproteinase MMP-9, but not MMP-3, enhances tau oligomer formation
G. Nuebling et al.
EXPERIMENTAL NEUROLOGY (2012)
Cerebrospinal Fluid Soluble Amyloid-β Protein Precursor as a Potential Novel Biomarkers of Alzheimer's Disease
Piotr Lewczuk et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Aβ1-42-RAGE Interaction Disrupts Tight Junctions of the Blood-Brain Barrier Via Ca2+-Calcineurin Signaling
Sun-Young Kook et al.
JOURNAL OF NEUROSCIENCE (2012)
Estrogen activates matrix metalloproteinases-2 and-9 to increase beta amyloid degradation
Sara Merlo et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2012)
Apolipoprotein E controls cerebrovascular integrity via cyclophilin A
Robert D. Bell et al.
NATURE (2012)
AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation
Xiao-Hong Li et al.
NEUROBIOLOGY OF AGING (2012)
Nuclear localization of Matrix metalloproteinases
Ferdinando Mannello et al.
PROGRESS IN HISTOCHEMISTRY AND CYTOCHEMISTRY (2012)
Regulation of matrix metalloproteinase 2 by oligomeric amyloid β protein
Wenjun Li et al.
BRAIN RESEARCH (2011)
Cerebrospinal Fluid Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Combination with Subcortical and Cortical Biomarkers in Vascular Dementia and Alzheimer's Disease
Maria Bjerke et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Structural Basis for Matrix Metalloproteinase-2 (MMP-2)-selective Inhibitory Action of β-Amyloid Precursor Protein-derived Inhibitor
Hiroshi Hashimoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Degradation of Soluble and Fibrillar Amyloid β-Protein by Matrix Metalloproteinase (MT1-MMP) in Vitro
Mei-Chen Liao et al.
BIOCHEMISTRY (2010)
The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity
Keith Brew et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
Hippocampal NMDA receptors and anxiety: At the interface between cognition and emotion
Christopher Barkus et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Matrix metalloproteinases in peripheral blood and cerebrospinal fluid in patients with Alzheimer's disease
Solveig Horstmann et al.
INTERNATIONAL PSYCHOGERIATRICS (2010)
Matrix metalloproteinase 3 haplotypes and plasma amyloid beta levels: The Rotterdam Study
Christiane Reitz et al.
NEUROBIOLOGY OF AGING (2010)
Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease
Erik Stomrud et al.
ALZHEIMERS RESEARCH & THERAPY (2010)
RAGE regulates BACE1 and Aβ generation via NFAT1 activation in Alzheimer's disease animal model
H. J. Cho et al.
FASEB JOURNAL (2009)
Propagation of Tau Misfolding from the Outside to the Inside of a Cell
Bess Frost et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9
Maya Koronyo-Hamaoui et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Restored degradation of the Alzheimer's amyloid-β peptide by targeting amyloid formation
Peter J. Crouch et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Increased Matrix Metalloproteinase 9 Activity in Mild Cognitive Impairment
Martin A. Bruno et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Matrix Metalloproteinase-9 Controls NMDA Receptor Surface Diffusion through Integrin β1 Signaling
Piotr Michaluk et al.
JOURNAL OF NEUROSCIENCE (2009)
Neuronal TIMP-1 Release Accompanies Astrocytic MMP-9 Secretion and Enhances Astrocyte Proliferation Induced by β-Amyloid 25-35 Fragment
Mar Hernandez-Guillamon et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
Matrix Metalloprotease-9 Inhibition Improves Amyloid β-Mediated Cognitive Impairment and Neurotoxicity in Mice
Hiroyuki Mizoguchi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
A beta-degrading enzymes in Alzheimer's disease
James Scott Miners et al.
BRAIN PATHOLOGY (2008)
Identification of amino acid residues of the matrix metalloproteinase-2 essential for its selective inhibition by β-amyloid precursor protein-derived inhibitor
Shouichi Higashi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Tissue inhibitor of metalloproteinases protect blood-brain barrier disruption in focal cerebral ischemia
Motoaki Fujimoto et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2008)
Human ProNGF: biological effects and binding profiles at TrkA, P75NTR and sortilin
Oliver Clewes et al.
JOURNAL OF NEUROCHEMISTRY (2008)
A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells
D. H. Choi et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Vesicular trafficking and secretion of matrix metalloproteinases-2,-9 and tissue inhibitor of metalloproteinases-1 in neuronal cells
Oualid Sbai et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2008)
Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia
Stefan Lorenzl et al.
INTERNATIONAL PSYCHOGERIATRICS (2008)
Alzheimer's disease and genetics of inflammation: a pharmacogenomic vision
Sonya Vasto et al.
PHARMACOGENOMICS (2007)
Abeta(1-40)-induced secretion of matrix metalloproteinase-9 results in sAPPα release by association with cell surface APP
Arginis A. Talamagas et al.
NEUROBIOLOGY OF DISEASE (2007)
Matrix metalloproteinases in brain development and remodeling: Synaptic functions and targets
Iryna M. Ethell et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
Impact of the matrix metalloproteinase MMP-3 on dementia
Nicole Helbecque et al.
NEUROBIOLOGY OF AGING (2007)
Induction of matrix metalloproteinases (MMP3, MMP12 and MMP13) expression in the microglia by amyloid-P stimulation via the PI3K/Akt pathway
Sachiko Ito et al.
EXPERIMENTAL GERONTOLOGY (2007)
Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction
James Haorah et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide
Christian Haass et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Effects of ApoE isoforms on beta-amyloid-induced matrix metalloproteinase-9 in rat astrocytes
Shuzhen Guo et al.
BRAIN RESEARCH (2006)
Matrix metalloproteinase-9 degrades amyloid-β fibrils in vitro and compact plaques in situ
Ping Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
TrkA-to-p75NTR molecular switch activates amyloid β-peptide generation during aging
C Costantini et al.
BIOCHEMICAL JOURNAL (2005)
Matrix metalloproteinase-9, its tissue inhibitor (TIMP)-1 and CRP in Alzheimer's disease
M Inspector et al.
EUROPEAN NEUROLOGY (2005)
Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease
JC Adair et al.
STROKE (2004)
分享论文
